Harrisburg Wellness Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Harrisburg Wellness Reporter.

Press releases published on September 14, 2026

Sep. 14, 2026

Phio Announces PH-762 Milestone with FDA Submission Supporting Clinical Development in Cutaneous Squamous Cell Carcinoma

Indeterminate EIN Presswire

Sep. 14, 2026

IDI Consulting Partners with the American Heart Association to Advance Heart Health Awareness

Indeterminate EIN Presswire

Sep. 14, 2026

Speech-Language Pathologist, and Mindset and Communication Specialist Renee Vee Recently Featured on Close Up Radio

Indeterminate EIN Presswire

Sep. 14, 2026

Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 14, 2026

From Former Patient to Clinical Leader: Oxford Treatment Center Promotes Kate Bell to Outpatient Clinical Manager

Indeterminate GlobeNewswire

Sep. 14, 2026

Ascendis Announces Planned $400 Million Share Repurchase Program

Indeterminate GlobeNewswire

Sep. 14, 2026

Ascendis to Regain Rights to TransCon® Technology in Metabolic and Cardiovascular Diseases

Indeterminate GlobeNewswire

Sep. 14, 2026

Curium™ announces FDA approval of BEXLUTRY lutetium Lu 177 dotatate injection for adults with SSTR-positive GEP-NETs

Indeterminate GlobeNewswire

Sep. 14, 2026

Onspire Health Marketing Clients Earn Five Gold Healthcare Advertising Awards

Indeterminate GlobeNewswire

Sep. 14, 2026

DLH Appoints Brooke Pierce President of Health Business Group

Indeterminate GlobeNewswire

Sep. 14, 2026

Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study

Indeterminate GlobeNewswire

Sep. 14, 2026

PetMeds Appoints Andrew Parry as Chief Technology Officer

Indeterminate GlobeNewswire

Sep. 14, 2026

Revolution Medicines Announces U.S. FDA Breakthrough Therapy Designation for RASONQUE™ (daraxonrasib) in Combination with Chemotherapy for First Line Metastatic Pancreatic Cancer

Indeterminate GlobeNewswire

Sep. 14, 2026

NurExone and NanoPass Technologies Ltd. to Collaborate on Integrated Exosome Delivery Approach for Regenerative Eye and Skin Applications

Indeterminate GlobeNewswire

Sep. 14, 2026

Sionna Therapeutics Announces Plans to Advance SION-451 + SION-2222 Dual Combination into Phase 2a Proof-of-Concept Trial

Indeterminate GlobeNewswire

Sep. 14, 2026

Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings

Indeterminate GlobeNewswire

Sep. 14, 2026

Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results

Indeterminate GlobeNewswire

Sep. 14, 2026

BioVie to Host Conference Call to Discuss Topline Data from Phase 2 ADDRESS-LC Trial and the Potential of Bezisterim in Long Covid

Indeterminate GlobeNewswire

Sep. 14, 2026

Benitec Biopharma Releases Full Year 2026 Financial Results and Provides Operational Update

Indeterminate GlobeNewswire

Sep. 14, 2026

Neutra Corp's Neutra Life Sciences Expands 2026 Industry Conference Schedule to Deepen Sponsor and CRO Relationships Across Its Site Network

Indeterminate GlobeNewswire